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Instrumentation
On a Dionex HPLC machine
(right picture) reverse phase
chromatography was conducted
with a c18 column (stationary
phase).The mobile phase for
Ampicillin was 20mM NaH2PO4
and Methanol (75:25) and for
Cefuroxime 20mM NaH2PO4 and
Methanol (80:20). UV detection
was at 210 nm for Ampicillin and
280 nm for Cefuroxime.

Cefuroxime
chromatogram
(left)

Linear Regression
6 calibration standards were plotted with their
peak area generating a line of best fit. The R2
value needed to be above 0.98. The y-intercept
error x2 needed to be larger than the y-intercept.
The y-intercept errors are 0.680 for Ampicillin
and 3.602 for Cefuroxime.

Area

Appropriate levels of an active
pharmaceutical ingredient (API) in medicines
must be present in a medical product for the
patient to receive therapeutic value. High
performance liquid chromatography (HPLC)
was used to develop a methodology to test
for the API in Ampicillin and Cefuroxime
drugs. Following the regulations of the
Distributed Pharmaceutical Analysis Lab
(DPAL) at the University of Notre Dame, the
sustainability requirements of linearity,
precision, accuracy/range, spike/degraded
spike, limit of detection /quantitation, tailing
factor, and number of theoretical plates were
experimentally determined to meet the
excepted standards.¹

Accuracy and Range

Ampicillin Chromatogram (right)
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The average of 35,100, and 150% runs were
used to find the measured experimental
concentration and their percent error ≤ 2%.
The relative standard deviation of the 200%
external standard were 0.690% (Ampicillin)
and 0.775% (Cefuroxime) both ≤2%.
Ampicillin

Theor.
Conc.

Exp. Conc.

Percent
Error

35%

0.0419

0.0421

0.480%

100%

0.102

0.0102

0%

150%

0.156

0.154

-1.28%

Cefuroxime

Theor.
Conc.

Exp. Conc.

Percent
Error

35%

0.0197

0.0202

2.54%

100%

0.0595

0.0596

0.168%

Spikes
From an Ampicillin tablet, a stock solution and
a spike solution (30% more concentrated) were
prepared, run, and subtracted from each other
to get the amount of pure standard added
0.031 mg/ml with a percent recovery of 107%.
An ampicillin tablet was heated at 60 degrees
for one hour to degrade it. A stock solution and
a degraded spike (30% more concentrated)
were prepared, run, and subtracted from each
other to get the amount of pure standard added
0.027 mg/ml with a percent recovery of 103%.

Calculations

A column efficiency
measurement, the number
of theoretical plates (N) are
6,620 for Ampicillin and
3368 for Cefuroxime. Tailing factor (T) is
1.5 for Ampicillin and for 1.6 for Cefuroxime.
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≤ 2%.
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